BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//University of Manitoba//UMFOD Calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:6a11fc31a3381@umanitoba.ca
SUMMARY:Investigator-Initiated Clinical Trials - Internal Deadline
DESCRIPTION:Investigator-Initiated Clinical Trials\n\nThis national program aims to:\n\n\n Advance new treatment options, particularly for rare, underserved and low survival cancers \n\n\n\n Evaluate innovative approaches to deliver more precise and effective care \n\n\n\n Improve patient outcomes and quality of life, including reducing treatment-related side effects \n\n\n\n Enhance early detection and diagnosis, enabling more timely interventions \n\n\n\n Strengthen prevention strategies aimed at reducing cancer incidence \n\n\nTwo funding streams available:\n\n\n Proof of Concept Trials $500,000 over 3 years.\n Full Clinical Trials $2M over 5 years.\n\n\n \n\n\nInternal Application Deadline: Aug 26, 2026 \n\nUMFOD Details: https://research.ad.umanitoba.ca/mrt/pubapp/umfo_view.php?id=4291\n\nProgram URL: https://cancerresearchsociety.ca/funding-programs/clinical-trials/\nInternal Deadline
X-ALT-DESC;FMTTYPE=text/html:Investigator-Initiated Clinical Trials
This national program aims to:
Advance new treatment options\, particularly for rare\, underserved and low survival cancers
Evaluate innovative approaches to deliver more precise and effective care
Improve patient outcomes and quality of life\, including reducing treatment-related side effects
Enhance early detection and diagnosis\, enabling more timely interventions
Strengthen prevention strategies aimed at reducing cancer incidence
Two funding streams available:
Proof of Concept Trials $500\,000 over 3 years.
Full Clinical Trials $2M over 5 years.
Internal Application Deadline: Aug 26\, 2026
UMFOD Details: https://research.ad.umanitoba.ca/mrt/pubapp/umfo_view.php?id=4291
Program URL: https://cancerresearchsociety.ca/funding-programs/clinical-trials/
DTSTART:20260826T083000
DTEND:20260826T093000
BEGIN:VALARM
TRIGGER:-P2D
ACTION:DISPLAY
DESCRIPTION:Reminder for Investigator-Initiated Clinical Trials
END:VALARM
END:VEVENT
END:VCALENDAR